• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Biomarkers

Sonde Health Secures $19.25M for Voice-Based Health Monitoring

by Fred Pennic 12/08/2022 Leave a Comment

Sonde Health Secures $19.25M for AI Vocal Biomarker Platform

What You Should Know: - Sonde Health, a Boston, MA-based health technology company committed to bringing accessible health monitoring to everyone raises $19.25 million in a Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures. - The AI vocal biomarker company will use the funding to accelerate its commercial growth, expand its platform into new health
Read More

How Biosensing Tech Can Alleviate Dehydration in Older Adults

by Jennifer Corso (Kukral), Upstream Marketing Manager, Physiology, Rockley Photonics 11/15/2022 Leave a Comment

How Biosensing Tech Can Alleviate Dehydration in Older Adults

For most adults, the first sign of dehydration is feeling thirsty. However, as we age, our thirst sensation naturally weakens, which means older people may not know that they need more fluids until they’re typically underhydrated, putting them at a higher risk of clinical dehydration. Other age-related physiological changes can also impact a person’s ability to remain hydrated, such as a decline in kidney function. Indeed, renal function begins to diminish around the age of 50. This is due
Read More

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers

by Syed Hamza Sohail 07/28/2022 Leave a Comment

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers

What You Should Know: - NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS). - This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More

Imagene Raises $21.5M to Expand Image-Based Biomarker Detection for Precision Medicine

by Fred Pennic 05/02/2022 Leave a Comment

Imagene Raises $21.5M to Expand Image-Based Biomarker Detection for Precision Medicine

What You Should Know: - Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced it raised $21.5 million, comprising $3M in seed funding led by Blumberg Capital and an $18.5M Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura. - The use of AI-based molecular testing in cancer diagnostics is revolutionizing patient care by offering a new level of
Read More

Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials

by Strategic Partnerships 04/01/2022 Leave a Comment

Medidata Announces Decentralized Clinical Trials Program

What You Should Know: - Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC
Read More

VivoSense Raises $25M for Wearable Sensor Biomarkers to Advance Clinical Trials

by Fred Pennic 03/30/2022 Leave a Comment

VivoSense Raises $25M for Wearable Sensor Biomarkers to Advance Clinical Trials

What You Should Know: - VivoSense, an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data raises $25 Million in Series A funding. - The financing will accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. VivoSense will also use this financing to expand and refine its informatics platform for data analysis from wearable and connected technologies to deliver validated digital
Read More

EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment in Children

by Jasmine Pennic 02/18/2022 Leave a Comment

EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment in Children

What You Should Know: - EarliTec Dx, a digital health company developing novel diagnostic and therapeutic products for children with Autism Spectrum Disorder (ASD) and early childhood vulnerabilities, today announced a $19.5 million financing led by Bernie Marcus, with participation from the Georgia Research Alliance (GRA). - This round of financing will be used to support filing with the U.S. Food and Drug Administration (FDA) for 510K clearance, as well as commercialization of the
Read More

GrayMatters Health Raises $10M for Biomarker-Based PTSD Therapeutics

by Fred Pennic 01/12/2022 Leave a Comment

GrayMatters Health Raises $10M for Biomarker-Based PTSD Therapeutics

What You Should Know: - GrayMatters Health (GMH), a company set to change the standards of mental health care with biomarker-based therapeutics, beginning with PTSD raises $10 million in Series A funding round led by Otsuka Medical Devices Co., Ltd., bringing total funding to $13.5 million. Additional investors in the Series A round included Joy Ventures, J-Ventures, and J-Impact. Existing GMH investors, Marius Nacht and Joyance Ventures, also
Read More

Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery

by Jasmine Pennic 09/13/2021 Leave a Comment

Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery

What You Should Know: - Medidata, a Dassault Systèmes company, today announced a first-of-its-kind partnership with Labcorp using the Medidata Sensor Cloud to introduce a new model to advance the use of medical-grade sensors in clinical trials and accelerate biomarker discovery. - As part of the partnership, Medidata will receive and process medical-grade sensor data within drug, vaccine and device trials across Labcorp Drug Development’s clinical trial portfolio,
Read More

Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection

by Fred Pennic 10/30/2020 Leave a Comment

Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection

What You Should Know: - Mayo Clinic announced a collaboration with Vocalis Health to to research and develop new voice-based tools for screening, detecting and monitoring patient health, beginning with a study to identify vocal biomarkers to detect pulmonary hypertension (PH). - The clinical validation study will utilize Vocalis Health’s proprietary software, which can operate on any connected voice platform (mobile, computer, tablet, etc.) to analyze patients’ health based on voice
Read More

  • Go to page 1
  • Go to page 2
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |